Certified by Founder Lodge
Med-Fine Capital
China - Shanghai
INVESTOR
1 Disclosed Funding Rounds $35,500,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Med-Fine Capital focuses on investment in healthcare and life sciences. The team has a deep background in healthcare industry and rich experience in venture capital. Headquartered in Shanghai
| Company | Date | Round | Raised |
|---|---|---|---|
Larkspur Biosciences |
May, 24 ,2023 | Unknown | $35,500,000 |
Larkspur Biosciences
dezerv.
FalconX
Kristal.AI
Finary
Savart
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)